Insulet (PODD) EPS (Weighted Average and Diluted) (2016 - 2026)
Insulet posted quarterly EPS (Weighted Average and Diluted) of $1.3 for Q1 2026, up 160.0% year-on-year from $0.5 in Q1 2025, and down 9.09% on a QoQ basis from $1.43 in Q4 2025.
Insulet (PODD) has 11 years of EPS (Weighted Average and Diluted) data on file, last reported at $1.3 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 160.0% year-over-year to $1.3; the trailing twelve-month figure through Mar 2026 stood at $4.29 (down 22.7% YoY), and the FY2025 full-year result was $3.48, down 39.79% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $1.3, down from $1.43 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $2.59 in Q2 2024 and bottomed at -$0.5 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is $0.73 (2024), against an average of $0.8.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) sank 144.44%; it then soared 1025.0% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.25 in 2022, then jumped by 488.0% to $1.47 in 2023, then slipped by 6.12% to $1.38 in 2024, then grew by 3.62% to $1.43 in 2025, then dropped by 9.09% to $1.3 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $1.3 (Q1 2026), $1.43 (Q4 2025), and $1.24 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn | 1.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 |
| Dec 31, 2025 | 1.43 |
| Sep 30, 2025 | 1.24 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 1.38 |
| Sep 30, 2024 | 1.08 |
| Jun 30, 2024 | 2.59 |
| Mar 31, 2024 | 0.73 |
| Dec 31, 2023 | 1.47 |
| Sep 30, 2023 | 0.74 |
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | 0.34 |
| Dec 31, 2022 | 0.25 |
| Sep 30, 2022 | -0.08 |
| Jun 30, 2022 | -0.50 |
| Mar 31, 2022 | 0.40 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.18 |
| Jun 30, 2021 | -0.37 |
| Dec 31, 2020 | -0.26 |
| Sep 30, 2020 | 0.17 |
| Jun 30, 2020 | 0.22 |
| Mar 31, 2020 | -0.03 |
| Dec 31, 2019 | 0.08 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.02 |
| Mar 31, 2019 | 0.07 |
| Dec 31, 2018 | 0.16 |
| Sep 30, 2018 | 0.03 |
| Jun 30, 2018 | -0.03 |
| Mar 31, 2018 | -0.11 |
| Dec 31, 2017 | -0.12 |
| Sep 30, 2017 | -0.04 |
| Dec 31, 2016 | 0.00 |